These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22265161)

  • 21. Hemolytic uremic syndrome with mild renal involvement due to Shiga toxin-producing Escherichia coli (STEC) O145 strain.
    Pérez L; Apezteguía L; Piñeyrúa C; Dabezies A; Bianco MN; Schelotto F; Varela G
    Rev Argent Microbiol; 2014; 46(2):103-6. PubMed ID: 25011592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical hemolytic-uremic syndrome: the interplay between complements and the coagulation system.
    Nayer A; Asif A
    Iran J Kidney Dis; 2013 Sep; 7(5):340-5. PubMed ID: 24072143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?
    Ruebner RL; Kaplan BS; Copelovitch L
    Eur J Pediatr; 2012 Oct; 171(10):1519-25. PubMed ID: 22673930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children].
    Ben Abdallah Chabchoub R; Boukedi A; Bensalah M; Maalej B; Gargour L; Turk F; Ben Halima N; Wolf M; Veyradier A; Mahfoudh A
    Arch Pediatr; 2013 Aug; 20(8):853-7. PubMed ID: 23827373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L
    Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].
    Visconti L; Cernaro V; Ardissino G; Sgarbanti M; Ferrara D; Visconti G; Santoro D; Buemi M
    G Ital Nefrol; 2017 Apr; 34(2):74-81. PubMed ID: 28682564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
    Westra D; Wetzels JF; Volokhina EB; van den Heuvel LP; van de Kar NC
    Neth J Med; 2012 Apr; 70(3):121-9. PubMed ID: 22516576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
    Avdonin PP; Blinova MS; Generalova GA; Emirova KM; Avdonin PV
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
    Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical haemolytic uraemic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?
    Nester CM; Thomas CP
    Hematology Am Soc Hematol Educ Program; 2012; 2012():617-25. PubMed ID: 23233643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemolytic-uremic syndrome].
    Bláhová K
    Vnitr Lek; 2004 Jul; 50(7):519-25. PubMed ID: 15323259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombotic microangiopathy after kidney transplantation.
    Noris M; Remuzzi G
    Am J Transplant; 2010 Jul; 10(7):1517-23. PubMed ID: 20642678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):833-839. PubMed ID: 28947259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HUS and the case for complement.
    Conway EM
    Blood; 2015 Oct; 126(18):2085-90. PubMed ID: 26396094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.